Acorda Therapeutics, Inc. (ACOR)
NASDAQ: ACOR · IEX Real-Time Price · USD
13.21
+1.11 (9.18%)
At close: Mar 28, 2024, 3:13 PM
13.98
+0.77 (5.82%)
After-hours: Mar 28, 2024, 4:41 PM EDT

Acorda Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2003
Net Income
-65.92-103.95-99.59-272.9733.68-223.36-34.6211.0617.6716.44
Upgrade
Depreciation & Amortization
32.8133.9541.334.5711.4823.2321.5815.018.477
Upgrade
Share-Based Compensation
1.4938.114.2521.2532.8136.433.2729.0725.05
Upgrade
Other Operating Activities
10.6925.66-10.8195.9884.38264.456.28-20.8619.44-9.2
Upgrade
Operating Cash Flow
-20.92-41.35-61.01-128.17150.7997.1429.6538.4874.6539.29
Upgrade
Operating Cash Flow Growth
----55.24%227.62%-22.95%-48.45%90.02%-24.62%
Upgrade
Capital Expenditures
-0.14-0.17-4.39-90.43-33.33-13.69-6.19-5.92-5.08-4.04
Upgrade
Acquisitions
00007.883.66-266.450-476.15-7.5
Upgrade
Change in Investments
073.9763.7589.92-150.830199.75-78.17190.11-30.43
Upgrade
Other Investing Activities
--0.03---0.59-0.69-0.89-1.15-2.7-3.12
Upgrade
Investing Cash Flow
-0.1473.7859.36-0.51-176.87-10.71-73.79-85.24-293.83-45.09
Upgrade
Share Issuance / Repurchase
000-0.0713.4510.4275.5218.116.0212.79
Upgrade
Debt Issued / Paid
0-69.66-1.67-60.48-0.66-2.41-1.590337.480
Upgrade
Other Financing Activities
-----53.51-28-0.31-0.19-0.82
Upgrade
Financing Cash Flow
0-69.66-1.67-60.5512.861.5245.9317.79353.3111.97
Upgrade
Exchange Rate Effect
0.51-0.451.020.06-0.411.23-2.16000
Upgrade
Net Cash Flow
-20.55-37.67-2.3-189.16-13.69149.17-0.36-28.97134.136.16
Upgrade
Free Cash Flow
-21.06-41.51-65.4-218.59117.4783.4523.4632.5669.5735.24
Upgrade
Free Cash Flow Growth
----40.76%255.75%-27.96%-53.19%97.39%-15.56%
Upgrade
Free Cash Flow Margin
-17.76%-32.16%-42.75%-113.61%24.92%14.18%4.51%6.61%17.33%10.48%
Upgrade
Free Cash Flow Per Share
-21.37-78.17-161.79-551.51299.85217.6962.1992.52202.86105.18
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).